Merck trumps revenues desires, increases purchases outlook on powerful need for best drugs like Keytruda - CNBC

.Merck trumps earnings assumptions, increases sales outlook on solid need for top medications like Keytruda CNBCMerck &amp Co. (MRK US) Beats Earnings Projections as Keytruda Sales Rise BloombergMerck Stock: Pharma Giant Posts Sturdy End Results, Yet Overview Drops Short Entrepreneur's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats income and purchases desires among Keytruda asset, yet delivers mixed full-year outlook MarketWatch.

Articles You Can Be Interested In

• Self-Help
• Career Advice
• Advertising
• Fitness
• Credit
• Video Production
• Management
• Online Marketing
• History
• Holidays
• Weddings
• Insurance
• Social Media
• Online Marketing
• Tax Planning
• Retail
• Blockchain
• Science
• Lifestyle
• Debt Management